PE Anti-DLL3 antibody [EPR22592-18],Abcam,AB305808

What is this antibody validated in? PE Anti-DLL3 antibody [EPR22592-18] (ab305808) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt) in Human samples. Related products Antibody clone EPR22592-18 is also available pre-conjugated to a variety of labels for your convenience – Anti-DLL3 PE [EPR22592-18] (ab305808). Other related products We have a range of other formats of antibody clone [EPR22592-18] also available for your convenience: ab229902 , Carrier free - ab255694 , PE - ab305808, APC - ab305809 , HRP - ab305810 , Alkaline Phosphatase - ab308729 , Alexa Fluor® 488 - ab309688 , Alexa Fluor® 647 - ab310054 , Alexa Fluor® 594 - ab310446 , Alexa Fluor® 555 - ab311973 , Alexa Fluor® 568 - ab312447 , Alexa Fluor® 750 - ab321469 How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .